Introducing a technological
revolution in digital medical diagnostics
Our minimally invasive technology addresses a number of disease state diagnostics including allergy testing, pain-free automated glucose monitoring, blood coagulation testing, tuberculosis (TB) testing and cholesterol monitoring.
The new age of digital electronic medical records (EMR) is here. SensiVida’s electro-optical diagnostic products will report directly to EMR’s with great accuracy and efficiency.This technological achievement in medical information management will make medical practice and health management more accurate,effective and efficient.
SensiVida also intends to develop "Molecular Optical Biopsy" medical devices that detect cancer using frequencies of light to distinguish cancer from normal tissues.
Letter to shareholders from CEO Kamal SarbadhikariMore »
Mediscience Technology Corporation Completes Acquisition Of SensiVida Medical Systems, Inc. Merged Entity Is SENSIVIDA MEDICAL TECHNOLOGIES, INC. With New Board And CEO – CTO Management, TeamMore »
MEDISCIENCE TECHNOLOGY CORP Files SEC Form 8-K, Entry Into A Material Definitive Agreement, Unregistered Sale Of EquityMore »